Scott K. Heysell

3.6k total citations
149 papers, 2.2k citations indexed

About

Scott K. Heysell is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Scott K. Heysell has authored 149 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Infectious Diseases, 92 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Scott K. Heysell's work include Tuberculosis Research and Epidemiology (114 papers), Mycobacterium research and diagnosis (52 papers) and Pneumocystis jirovecii pneumonia detection and treatment (31 papers). Scott K. Heysell is often cited by papers focused on Tuberculosis Research and Epidemiology (114 papers), Mycobacterium research and diagnosis (52 papers) and Pneumocystis jirovecii pneumonia detection and treatment (31 papers). Scott K. Heysell collaborates with scholars based in United States, Tanzania and Netherlands. Scott K. Heysell's co-authors include Eric R. Houpt, Stellah Mpagama, Jean Gratz, Gibson Kibiki, Suporn Pholwat, Jan‐Willem C. Alffenaar, Tania A. Thomas, Tawanda Gumbo, J. R. Reynolds and Charles A. Peloquin and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Scott K. Heysell

138 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott K. Heysell United States	26	1.7k	1.3k	533	425	259	149	2.2k
Rovina Ruslami Indonesia	25	2.0k 1.2×	1.4k 1.1×	1.1k 2.0×	334 0.8×	298 1.2×	107	3.1k
Thuli Mthiyane South Africa	16	1.2k 0.7×	913 0.7×	428 0.8×	142 0.3×	214 0.8×	28	1.5k
Simon Tiberi United Kingdom	29	2.2k 1.3×	1.4k 1.1×	740 1.4×	156 0.4×	618 2.4×	84	3.0k
Angela M. Crook United Kingdom	24	1.6k 1.0×	1.1k 0.9×	713 1.3×	125 0.3×	302 1.2×	52	2.6k
Amour Venter South Africa	27	2.3k 1.4×	1.7k 1.3×	713 1.3×	356 0.8×	714 2.8×	43	2.8k
Russell R. Kempker United States	29	1.7k 1.0×	1.2k 0.9×	606 1.1×	121 0.3×	305 1.2×	127	2.4k
Elin M. Svensson Sweden	24	1.0k 0.6×	688 0.5×	256 0.5×	313 0.7×	229 0.9×	91	1.6k
Geraint Davies United Kingdom	31	2.1k 1.3×	1.5k 1.2×	559 1.0×	352 0.8×	423 1.6×	136	3.0k
T. Schaberg Germany	29	1.0k 0.6×	2.1k 1.7×	541 1.0×	370 0.9×	147 0.6×	125	3.5k
Shashikant Srivastava United States	32	2.2k 1.3×	1.8k 1.4×	424 0.8×	727 1.7×	434 1.7×	126	2.9k

Countries citing papers authored by Scott K. Heysell

Since Specialization

Citations

This map shows the geographic impact of Scott K. Heysell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott K. Heysell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott K. Heysell more than expected).

Fields of papers citing papers by Scott K. Heysell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott K. Heysell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott K. Heysell. The network helps show where Scott K. Heysell may publish in the future.

Co-authorship network of co-authors of Scott K. Heysell

This figure shows the co-authorship network connecting the top 25 collaborators of Scott K. Heysell. A scholar is included among the top collaborators of Scott K. Heysell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott K. Heysell. Scott K. Heysell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Githinji, George, Zaydah R. de Laurent, Khadija Said Mohammed, et al.. (2025). Deploying Metagenomics to Characterize Microbial Pathogens During Outbreak of Acute Febrile Illness Among Children in Tanzania. Pathogens. 14(6). 601–601.

Mtei, Frank, Praveen Kumar Neema, Patrick Howlett, et al.. (2024). A call to invest in post-TB lung disease to halt TB transmission in communities. SHILAP Revista de lepidopterología. 1(2). 96–98.

Abouzid, Mohamed, Katarzyna Kosicka, Marta Karaźniewicz‐Łada, et al.. (2024). Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. Molecules. 29(2). 337–337. 2 indexed citations

Singh, Sanjay, Tawanda Gumbo, Jann‐Yuan Wang, et al.. (2024). Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. The Journal of Infectious Diseases. 231(6). 1521–1531. 3 indexed citations

Keim‐Malpass, Jessica, Scott K. Heysell, Tania A. Thomas, et al.. (2023). Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda. International Journal of Environmental Research and Public Health. 20(6). 5041–5041.

Mpagama, Stellah, Hadija Semvua, Derek J. Sloan, et al.. (2023). Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania. Pilot and Feasibility Studies. 9(1). 55–55. 2 indexed citations

Mpagama, Stellah, Albino Kalolo, Kaushik Ramaiya, et al.. (2023). Clinical Audit for Integration of Communicable and Non-Communicable Diseases at the Primary Health Care Level in Tanzania. PubMed. 7(2). 241–248.

Singh, Sanjay, Jann‐Yuan Wang, Scott K. Heysell, et al.. (2023). Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease. International Journal of Antimicrobial Agents. 62(1). 106847–106847. 14 indexed citations

Ntinginya, Nyanda Elias, Scott K. Heysell, Kaushik Ramaiya, et al.. (2023). Point-of-care Glycated Hemoglobin A1c Testing for the Identification of Hyperglycemia Severity among Individuals with Dual Tuberculosis and Diabetes Mellitus in Tanzania. International Journal of Mycobacteriology. 12(4). 429–435. 1 indexed citations

10.

Donlan, Alexandra N., Z. Jennie, Heather M. Haughey, et al.. (2022). Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial. Open Forum Infectious Diseases. 9(8). ofac343–ofac343. 19 indexed citations

11.

Singh, Sanjay, et al.. (2022). Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii. Tuberculosis. 138. 102289–102289. 1 indexed citations

12.

Heysell, Scott K.. (2022). Extrapulmonary tuberculosis. The biomedical & life sciences collection.. 2022(4). e1005551–e1005551.

13.

Maro, Athanasia, Jean Gratz, Mohammad H. Al‐Shaer, et al.. (2022). Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing. Tuberculosis. 136. 102246–102246. 8 indexed citations

14.

Mpolya, Emmanuel, Elingarami Sauli, Bariki Mtafya, et al.. (2021). Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania. Journal of Clinical Microbiology. 59(4). 15 indexed citations

15.

Alffenaar, Jan‐Willem C., Anne‐Grete Märtson, Scott K. Heysell, et al.. (2021). Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections. Clinical Pharmacokinetics. 60(6). 711–725. 29 indexed citations

16.

Srivastava, Shashikant, Jann‐Yuan Wang, Gesham Magombedze, et al.. (2021). Novel Short-Course Therapy and Morphism Mapping for Clinical Pulmonary Mycobacterium kansasii. Antimicrobial Agents and Chemotherapy. 65(5). 7 indexed citations

17.

Perumal, Rubeshan, Kogieleum Naidoo, Anushka Naidoo, et al.. (2020). A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes. The International Journal of Tuberculosis and Lung Disease. 24(1). 48–64. 21 indexed citations

18.

Огарков, О. Б., et al.. (2016). Administrative interventions associated with increased initiation on antiretroviral therapy in Irkutsk, Siberia. Public Health Action. 6(4). 252–254. 9 indexed citations

19.

Mpagama, Stellah, Charles Mtabho, Solomon Mwaigwisya, et al.. (2012). Comparison of Overnight Pooled and Standard Sputum Collection Method for Patients with Suspected Pulmonary Tuberculosis in Northern Tanzania. SHILAP Revista de lepidopterología. 2012. 1–5. 13 indexed citations

20.

Shah, Neha, Prashini Moodley, Palav Babaria, et al.. (2011). Rapid Diagnosis of Tuberculosis and Multidrug Resistance by the Microscopic-Observation Drug-Susceptibility Assay. American Journal of Respiratory and Critical Care Medicine. 183(10). 1427–1433. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact